{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:10:18Z","timestamp":1784232618784,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.117025","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:32:05Z","timestamp":1781764325000},"page":"117025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["DLX2 drives vascular calcification in chronic kidney disease through glycolytic activation: a mechanism epigenetically regulated by HDAC2"],"prefix":"10.1016","volume":"185","author":[{"given":"Qun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10075","key":"10.1016\/j.intimp.2026.117025_bb0005","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2026.117025_bb0010","first-page":"S17","article-title":"Vascular calcification in end-stage renal disease","volume":"17","author":"Jablonski","year":"2013","journal-title":"Hemodial. Int."},{"issue":"3","key":"10.1016\/j.intimp.2026.117025_bb0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00109-021-02037-7","article-title":"Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches","volume":"99","author":"D\u00fcsing","year":"2021","journal-title":"J. Mol. Med. (Berl)"},{"issue":"23","key":"10.1016\/j.intimp.2026.117025_bb0020","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","article-title":"Medial vascular calcification revisited: review and perspectives","volume":"35","author":"Lanzer","year":"2014","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.intimp.2026.117025_bb0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacbts.2020.02.002","article-title":"Targeting vascular calcification in chronic kidney disease","volume":"5","author":"Nelson","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117025_bb0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3810\/pgm.2014.03.2740","article-title":"The molecular biology and pathophysiology of vascular calcification","volume":"126","author":"McCarty","year":"2014","journal-title":"Postgrad. Med."},{"issue":"24","key":"10.1016\/j.intimp.2026.117025_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413536","article-title":"Vascular calcification: key roles of phosphate and pyrophosphate","volume":"22","author":"Villa-Bellosta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117025_bb0040","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301429R","article-title":"HDAC2 counteracts vascular calcification by activating autophagy in chronic kidney disease","volume":"38","author":"Zhou","year":"2024","journal-title":"FASEB J."},{"issue":"48","key":"10.1016\/j.intimp.2026.117025_bb0045","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1523\/JNEUROSCI.0735-22.2022","article-title":"HDAC2 in primary sensory neurons constitutively restrains chronic pain by repressing \u03b12\u03b4-1 expression and associated NMDA receptor activity","volume":"42","author":"Zhang","year":"2022","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117025_bb0050","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1242\/dev.100487","article-title":"A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog","volume":"141","author":"Hagelkruys","year":"2014","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.intimp.2026.117025_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108272","article-title":"DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.intimp.2026.117025_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41368-019-0046-1","article-title":"Overexpression of Dlx2 enhances osteogenic differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of osteocalcin and alp","volume":"11","author":"Zhang","year":"2019","journal-title":"Int. J. Oral Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117025_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00441-014-1833-9","article-title":"Distal-less homeobox 2 promotes the osteogenic differentiation potential of stem cells from apical papilla","volume":"357","author":"Qu","year":"2014","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117025_bb0070","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3892\/ijo.2015.2874","article-title":"Dlx-2 is implicated in TGF-\u03b2- and Wnt-induced epithelial-mesenchymal, glycolytic switch, and mitochondrial repression by snail activation","volume":"46","author":"Lee","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117025_bb0075","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300900R","article-title":"PFKFB3-driven vascular smooth muscle cell glycolysis promotes vascular calcification via the altered FoxO3 and lactate production","volume":"37","author":"Chen","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2026.117025_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellsig.2019.03.006","article-title":"Lactate accelerates calcification in VSMCs through suppression of BNIP3-mediated mitophagy","volume":"58","author":"Zhu","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2026.117025_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144564","article-title":"DLX2 activates Wnt1 transcription and mediates Wnt\/\u03b2-catenin signal to promote osteogenic differentiation of hBMSCs","volume":"744","author":"Zeng","year":"2020","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.intimp.2026.117025_bb0090","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1111\/jcmm.14611","article-title":"Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt\/\u03b2-catenin pathway","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"11","key":"10.1016\/j.intimp.2026.117025_bb0095","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/CIRCRESAHA.123.323699","article-title":"Orphan nuclear receptor NR4A3 promotes vascular calcification via histone Lactylation","volume":"134","author":"Ma","year":"2024","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.117025_bb0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/cvr\/cvs278","article-title":"Induction of intracellular heat-shock protein 72 prevents the development of vascular smooth muscle cell calcification","volume":"96","author":"Lu","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2026.117025_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107995","article-title":"Reprogrammed glucose metabolism in vascular smooth muscle cells and its implications for vascular diseases","volume":"221","author":"Ma","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.intimp.2026.117025_bb0110","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00109-020-01925-8","article-title":"Impact of \u03b2-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells","volume":"98","author":"Alesutan","year":"2020","journal-title":"J. Mol. Med. (Berl)"},{"issue":"24","key":"10.1016\/j.intimp.2026.117025_bb0115","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401649RR","article-title":"O-GlcNAc transferase promotes vascular smooth muscle calcification through modulating Wnt\/\u03b2-catenin signaling","volume":"38","author":"Xu","year":"2024","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.intimp.2026.117025_bb0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/SHK.0000000000002488","article-title":"Zbtb16 drives vascular calcification through accelerating vsmcs osteoblastic transition in chronic kidney disease via wnt\/\u03b2-catenin pathway","volume":"63","author":"Shen","year":"2025","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.intimp.2026.117025_bb0125","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1161\/ATVBAHA.124.321793","article-title":"TRPV4 promotes vascular calcification by directly associating with and activating \u03b2-catenin","volume":"45","author":"Yuan","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"21","key":"10.1016\/j.intimp.2026.117025_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215557","article-title":"The key role of the WNT\/\u03b2-catenin pathway in metabolic reprogramming in cancers under normoxic conditions","volume":"13","author":"Vall\u00e9e","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117025_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2019.05.024","article-title":"Metabolic reprogramming in atherosclerosis: opposed interplay between the canonical WNT\/\u03b2-catenin pathway and PPAR\u03b3","volume":"133","author":"Vall\u00e9e","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117025_bb0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/s12967-024-05605-w","article-title":"BRCC36 regulates \u03b2-catenin ubiquitination to alleviate vascular calcification in chronic kidney disease","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117025_bb0145","doi-asserted-by":"crossref","first-page":"34039","DOI":"10.1038\/s41598-025-13352-1","article-title":"Zinc alleviates vascular calcification by activating ERK1\/2-mediated autophagy","volume":"15","author":"Guo","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117025_bb0150","article-title":"Ultrasmall cu(2-x)se nanoparticles alleviate vascular calcification through inhibiting oxidative stress and NF-\u03baB\/NLRP3-mediated inflammation","volume":"89","author":"Liu","year":"2025","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117025_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/apm.70097","article-title":"Circulating miR-378a-3p screens end-stage renal disease patients, predicts the occurrence of MACEs, and regulates vascular calcification via targeting SULF1","volume":"133","author":"Li","year":"2025","journal-title":"Apmis"},{"issue":"21","key":"10.1016\/j.intimp.2026.117025_bb0160","article-title":"GLS1-mediated redundancy in glutamate accelerates arterial calcification via activating NMDAR\/ca(2+)\/\u03b2-catenin pathway","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci. (Weinh)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926008714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:42:17Z","timestamp":1784230937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926008714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S1567576926008714"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117025","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DLX2 drives vascular calcification in chronic kidney disease through glycolytic activation: a mechanism epigenetically regulated by HDAC2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117025"}}